Sign In
Buy CTLT
$63.49
+0 (+0%)
At Close: Mar 14, 2025
Shares of Wegovy Partner Catalent Jump After Striking Deal With Activist Investor Elliott
12:05pm, Tuesday, 29'th Aug 2023
Catalent (CTLT) shares surged more than 5% in early trading on Tuesday after the struggling drugmaker secured a deal with activist investor Elliott Investment Management.
Catalent nears deal with Elliott Investment Management; will explore company sale
10:22am, Tuesday, 29'th Aug 2023
Catalent Inc is close to a settlement deal with activist investor Elliott Investment Management, which will include the appointment new directors and a pledge to review strategic alternatives such as
Catalent (CTLT) Stock Gains on Elliott Deal
09:55am, Tuesday, 29'th Aug 2023
Catalent (NYSE: CTLT ) stock is getting a boost on Tuesday after the consumer health company reached an agreement with Elliott Investment Management. This has Catalent adding four new directors to its
Catalent (CTLT) Q4 Earnings Miss Estimates
09:46am, Tuesday, 29'th Aug 2023
Catalent (CTLT) came out with quarterly earnings of $0.09 per share, missing the Zacks Consensus Estimate of $0.10 per share. This compares to earnings of $1.19 per share a year ago.
Catalent stock jumps after cooperation agreement with activist investor Elliott Investment
07:30am, Tuesday, 29'th Aug 2023
Shares of Catalent Inc. CTLT, +1.67% jumped 4.1% in premarket trading Tuesday, after the maker of products used by drug makers and consumer health companies announced an cooperation agreement with act
Exclusive: Catalent nears settlement with Elliott for board seats -sources
05:01pm, Monday, 28'th Aug 2023
Catalent Inc is close to reaching a settlement with Elliott Investment Management that would lead to a shake-up of the U.S. contract drug manufacturer's board of directors after its share price lost h
Exclusive: Catalent's Indiana plant to make Novo's Wegovy weight-loss drug-sources
10:52am, Friday, 25'th Aug 2023
Catalent's plant in Bloomington, Indiana, will fill injection pens for Novo Nordisk's weight-loss drug Wegovy as part of the two companies' expanded supply agreement, two sources familiar with the mat
Catalent, Inc. Announces Fourth Quarter Fiscal Year 2023 Earnings Conference Webcast
09:14am, Tuesday, 22'nd Aug 2023
SOMERSET, N.J.--(BUSINESS WIRE)--Catalent, Inc. (NYSE: CTLT), the leader in enabling the development and supply of better treatments for patients worldwide, today announced that it will release financ
Strong Earnings, Troubled Stocks: 3 Companies That May Light Up Volatility Screens
04:06pm, Monday, 21'st Aug 2023
Equities have pulled back from their late July highs, though the Q2 reporting season has been solid. We spot three firms with unusual corporate event activity. A problem child is back at the top of ou
As Ozempic/Wegovy frenzy continues, Morgan Stanley lifts forecasts for weight-loss drugs to $77 billion
05:05am, Friday, 21'st Jul 2023
Morgan Stanley on Friday lifted its forecast for annual sales of weight-loss drugs to $77 billion, as patient demand for the medicines has outstripped supply and been fueled by a social-media frenzy.
Catalent shares jump 10% on Elliott news
01:10pm, Thursday, 20'th Jul 2023
Catalent Inc (NYSE: CTLT) jumped nearly 10% this morning after Elliott Investment Management was reported to have built a sizable stake in the contract drug manufacturer.
Catalent stock rises on reports Elliot Investment has taken a significant stake
12:33pm, Thursday, 20'th Jul 2023
Catalent stock moved higher on Thursday on reports that activist investor Elliot Investment Management has taken a significant stake in the company. Shares of the contract drugmaker had added 4% at US
Catalent stock jumps on report of activist investor Elliott taking stake
10:57am, Thursday, 20'th Jul 2023
Yahoo Finance Live's Diane King Hall and Julie Hyman report on Catalent stock as Elliott takes stake in the company.
CTLT Stock Alert: What to Know as Elliott Takes a Stake in Catalent
09:12am, Thursday, 20'th Jul 2023
Catalent (NYSE: CTLT ) stock is on the move Thursday as investors react to activist investor Elliott Investment taking a stake in the drug-making company. Specific details of the stake Elliott Investm
Elliott Takes Big Stake in Drugmaker Catalent
06:51pm, Wednesday, 19'th Jul 2023
The activist is pushing for a shake-up of the contract drug manufacturer's board.
